Biomarker Research
Accelerate drug discovery while maintaining absolute HIPAA/GDPR compliance.
Rare disease research requires global scale, but patient privacy laws create dead ends. OpenMatter allows institutions to cross-reference sensitive biomarker libraries without raw medical records ever leaving the local jurisdiction.






